QUINTILES
LIVE

Serial Number

77244438

Owner

IQVIA INC.

Attorney

Arlene D. Hanks

First Use Date

Feb 1, 1982

Filing Date

Aug 1, 2007

Add to watchlist:

No watchlists yet
View on USPTO

QUINTILES Trademark

Serial Number: 77244438 • Registration: 3565448

QUINTILES is a trademark filed by IQVIA INC. on August 1, 2007. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

IQVIA INC. (81 trademarks)

100 IMS DRIVE
PARSIPPANY, NJ 07054

Entity Type: 03

QUINTILES TRANSNATIONAL CORP. (78 trademarks)

Suite 200
Durham, NC 27703

Entity Type: 03

Trademark Details

Filing Date

August 1, 2007

Registration Date

January 20, 2009

First Use Anywhere

February 1, 1982

First Use in Commerce

February 1, 1982

Published for Opposition

March 18, 2008

Goods & Services

[ Educational and training services, namely, conducting training programs, seminars, classes, conferences and workshops in the fields of health care, health management and disease management, pharmaceutical sales skills, and pharmaceutical and health products, and distributing course materials in connection therewith ]

Computerized database management and data processing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; manufacturers' and independent sales representatives in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; marketing services for others, namely, creating and managing product sales and product launch programs in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; business marketing consulting services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; market research and analysis services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; [ personnel recruitment and placement; ] providing business information, namely, information useful for achieving and maintaining regulatory approval and market introduction of drugs, devices and biologics

Regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation services in the field of compliance evaluation to insure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consulting services in the fields of regulatory affairs, manufacturing compliance and validation; providing regulatory information and implementation services relating to the development and validation of drugs, devices and biologics

Providing health, medical, dental, pharmaceutical, health management and disease management information to others; medical evaluation services, namely, developing and implementing disease management and treatment protocols and patient outcome analysis services; consulting services in the fields of health care, medical and pharmaceuticals, veterinary, and dental services

Clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices; product development consultation in the fields of medical products and devices; healthcare policy research and development services; laboratory testing services in the fields of pharmaceutical, pharmacogenomic, biotechnical and medical products and devices; consultancy pertaining to pharmacology and biotechnical research; managing, monitoring and coordinating clinical studies on human subjects for others

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Feb 14, 2019 NAS8
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Feb 14, 2019 RNL1
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
Feb 14, 2019 9G8P
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
Feb 14, 2019 8PRT
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 14, 2019 APRE
TEAS SECTION 8 & 9 RECEIVED
Jan 15, 2019 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 18, 2018 TCCA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 17, 2018 ASGN
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 1, 2018 ASCK
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 20, 2018 REM2
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 19, 2016 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 12, 2016 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 27, 2015 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
May 20, 2015 ASCK
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 8, 2015 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 8, 2015 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 8, 2015 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 17, 2014 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 17, 2014 TCCA
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 22, 2009 ASCK
REGISTERED-PRINCIPAL REGISTER
Jan 20, 2009 R.PR
LAW OFFICE REGISTRATION REVIEW COMPLETED
Dec 17, 2008 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 17, 2008 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 26, 2008 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 26, 2008 AITU
USE AMENDMENT FILED
Nov 20, 2008 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 20, 2008 EISU
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 10, 2008 NOAM
PUBLISHED FOR OPPOSITION
Mar 18, 2008 PUBO
NOTICE OF PUBLICATION
Feb 27, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 13, 2008 PREV
ASSIGNED TO LIE
Feb 13, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 14, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2007 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2007 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 26, 2007 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 23, 2007 GNRN
NON-FINAL ACTION E-MAILED
Oct 23, 2007 GNRT
NON-FINAL ACTION WRITTEN
Oct 23, 2007 CNRT
EXAMINER'S AMENDMENT ENTERED
Oct 19, 2007 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 19, 2007 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 19, 2007 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 19, 2007 CNEA
ASSIGNED TO EXAMINER
Oct 17, 2007 DOCK
NEW APPLICATION ENTERED
Aug 6, 2007 NWAP